JP2013163673A5 - - Google Patents

Download PDF

Info

Publication number
JP2013163673A5
JP2013163673A5 JP2013024857A JP2013024857A JP2013163673A5 JP 2013163673 A5 JP2013163673 A5 JP 2013163673A5 JP 2013024857 A JP2013024857 A JP 2013024857A JP 2013024857 A JP2013024857 A JP 2013024857A JP 2013163673 A5 JP2013163673 A5 JP 2013163673A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
seq
acid sequence
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013024857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013163673A (ja
JP5738333B2 (ja
Filing date
Publication date
Priority claimed from GB0516527A external-priority patent/GB0516527D0/en
Priority claimed from GB0609920A external-priority patent/GB0609920D0/en
Priority claimed from GB0609921A external-priority patent/GB0609921D0/en
Application filed filed Critical
Publication of JP2013163673A publication Critical patent/JP2013163673A/ja
Publication of JP2013163673A5 publication Critical patent/JP2013163673A5/ja
Application granted granted Critical
Publication of JP5738333B2 publication Critical patent/JP5738333B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013024857A 2005-08-11 2013-02-12 自己免疫疾患の治療及び診断のためのｔｃｒ−ｖベータ関連ペプチド Expired - Fee Related JP5738333B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0516527.9 2005-08-11
GB0516527A GB0516527D0 (en) 2005-08-11 2005-08-11 Peptides
GB0609920A GB0609920D0 (en) 2006-05-18 2006-05-18 Peptides
GB0609920.4 2006-05-18
GB0609921.2 2006-05-18
GB0609921A GB0609921D0 (en) 2006-05-18 2006-05-18 Peptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008525635A Division JP2009505640A (ja) 2005-08-11 2006-08-09 自己免疫疾患の治療及び診断のためのｔｃｒ−ｖベータ関連ペプチド

Publications (3)

Publication Number Publication Date
JP2013163673A JP2013163673A (ja) 2013-08-22
JP2013163673A5 true JP2013163673A5 (https=) 2014-03-06
JP5738333B2 JP5738333B2 (ja) 2015-06-24

Family

ID=37056087

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008525635A Pending JP2009505640A (ja) 2005-08-11 2006-08-09 自己免疫疾患の治療及び診断のためのｔｃｒ−ｖベータ関連ペプチド
JP2013024857A Expired - Fee Related JP5738333B2 (ja) 2005-08-11 2013-02-12 自己免疫疾患の治療及び診断のためのｔｃｒ−ｖベータ関連ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008525635A Pending JP2009505640A (ja) 2005-08-11 2006-08-09 自己免疫疾患の治療及び診断のためのｔｃｒ−ｖベータ関連ペプチド

Country Status (17)

Country Link
US (1) US9243062B2 (https=)
EP (3) EP1919952B1 (https=)
JP (2) JP2009505640A (https=)
KR (2) KR101527334B1 (https=)
CN (1) CN105017423B (https=)
AU (1) AU2006277785B2 (https=)
BR (1) BRPI0614366A2 (https=)
CA (1) CA2618796C (https=)
CU (1) CU23793B7 (https=)
CY (1) CY1120640T1 (https=)
DK (1) DK2594591T3 (https=)
EA (1) EA015629B1 (https=)
ES (1) ES2679994T3 (https=)
GB (1) GB2429013C (https=)
IL (3) IL189407A (https=)
NZ (3) NZ566245A (https=)
WO (1) WO2007017686A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
HRP20140240T4 (hr) 2005-11-30 2017-02-24 Abbvie Inc. Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
EP2154969B1 (en) * 2007-05-16 2015-11-18 The Brigham and Women's Hospital, Inc. Treatment of synucleinopathies
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
NZ581835A (en) * 2007-06-12 2012-09-28 Ac Immune Sa Monoclonal anti beta amyloid antibody
AU2008311367B2 (en) 2007-10-05 2014-11-13 Ac Immune S.A. Use of anti-amyloid beta antibody in ocular diseases
WO2010053209A1 (en) * 2008-11-05 2010-05-14 Fujirebio Inc. Method for sensing a biochemical and/or biomechanical process of a biological material and method for analyzing biological materials
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP2598882B1 (en) 2010-07-30 2017-07-26 AC Immune S.A. Safe and functional humanized antibodies for use in treating an amyloidosis
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies
WO2012047732A2 (en) * 2010-09-29 2012-04-12 Genentech, Inc. Antibody compositions and methods of use
CN107831318B (zh) * 2011-01-20 2021-06-18 西瑞斯实验室有限公司 检测谷蛋白敏感性和其区分于乳糜泻的方法和装置
BR112014029417B1 (pt) 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia
JP6153019B2 (ja) 2013-01-31 2017-06-28 国立大学法人 東京大学 リゾホスファチジルセリン受容体機能調節活性を有する化合物
EP3083697B1 (en) * 2013-12-20 2019-04-17 Development Center for Biotechnology Alpha-enolase specific antibodies and methods of uses in cancer therapy
WO2015114576A1 (en) * 2014-01-31 2015-08-06 Universität Zürich Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease
JP6369721B2 (ja) 2014-07-04 2018-08-08 国立大学法人 東京大学 リゾホスファチジルセリン誘導体
GB2532426B (en) * 2014-11-18 2016-11-02 Rogers Arpi Therapeutic homodimer and uses thereof
AU2014415566A1 (en) * 2014-12-31 2017-07-20 Develpment Center For Biotechnology Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy
US9527922B2 (en) 2014-12-31 2016-12-27 Development Center For Biotechnology Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy
KR101802302B1 (ko) 2015-01-21 2017-11-28 가천대학교 산학협력단 포스파티딜이노시톨포스페이트 결합 물질의 세포 사멸 검출 용도
JP6544669B1 (ja) 2018-03-16 2019-07-17 ディヴェロップメント センター フォー バイオテクノロジー アルファエノラーゼに特異的な抗体及びその使用
WO2019197610A1 (en) 2018-04-13 2019-10-17 INSERM (Institut National de la Santé et de la Recherche Médicale) New vaccinal strategy
CN110885778A (zh) * 2018-09-07 2020-03-17 上海益诺思生物技术股份有限公司 从体外培养的细胞中分离Pig-a基因突变细胞的方法
AU2020346886A1 (en) * 2019-09-13 2022-04-14 Memorial Hospital For Cancer And Allied Diseases Anti-CD371 antibodies and uses thereof
GB202015755D0 (en) * 2020-10-05 2020-11-18 Rogers Arpi Coronavirus therapy

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
EP0388186A1 (en) 1989-03-17 1990-09-19 E.I. Du Pont De Nemours And Company External regulation of gene expression
US5795965A (en) * 1991-04-25 1998-08-18 Chugai Seiyaku Kabushiki Kaisha Reshaped human to human interleukin-6 receptor
SE9102074D0 (sv) * 1991-07-03 1991-07-03 Kabi Pharmacia Ab Tomour antigen specific antibody
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5891623A (en) * 1992-11-09 1999-04-06 Consorzio Per Le Biotecnologie Diagnosis and treatment of AIDS onset
GB9317423D0 (en) 1993-08-21 1993-10-06 Imp Cancer Res Tech Monoclonal antibodies
US5362865A (en) 1993-09-02 1994-11-08 Monsanto Company Enhanced expression in plants using non-translated leader sequences
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US6001809A (en) 1994-07-11 1999-12-14 Elan Pharmaceuticals, Inc. Inhibitors of leukocyte adhesion
USRE39048E1 (en) * 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
US5861260A (en) 1996-11-05 1999-01-19 University Of Massachusetts Diagnostic methods for screening patients for scleroderma
IL121041A0 (en) 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
EP1595951A1 (en) * 1997-07-21 2005-11-16 Arpi Matossian-Rogers Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
DE19739685A1 (de) 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile
US7083950B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. High affinity fusion proteins and therapeutic and diagnostic methods for use
US6703491B1 (en) * 1999-03-17 2004-03-09 Exelixis, Inc. Drosophila sequences
EP1212422B1 (en) 1999-08-24 2007-02-21 Medarex, Inc. Human ctla-4 antibodies and their uses
SI1232392T1 (en) * 1999-10-12 2003-10-31 Connex Gesellschaft Zur Optimierung Von Forschung Und Improved method for the detection of acid resistant bacteria of the genus helicobacter in stool
EP1130032A1 (en) * 2000-02-28 2001-09-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)
GB0006398D0 (en) * 2000-03-16 2000-05-03 Novartis Ag Organic compounds
JP2001299349A (ja) * 2000-04-19 2001-10-30 Suntory Ltd 新規組換え型抗体とそのｃｄｒのアミノ酸配列およびそれをコードする遺伝子
CU23007A1 (es) 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US20040115196A1 (en) * 2001-04-18 2004-06-17 Yoshiaki Fukuda Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
WO2002098897A2 (en) * 2001-06-01 2002-12-12 Cornell Research Foundation, Inc. Modified antibodies to prostate-specific membrane antigen and uses thereof
EP1427377A4 (en) 2001-09-20 2006-04-12 Cornell Res Foundation Inc METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SKIN DISORDERS USING SPECIFIC BINDING AGENTS FOR A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
CA2478047C (en) * 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
US8038986B2 (en) * 2002-07-26 2011-10-18 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
US20040136998A1 (en) * 2002-10-30 2004-07-15 Bander Neil H. Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen
US20050009136A1 (en) * 2003-02-19 2005-01-13 Dyax Corporation PAPP-A ligands
KR100500283B1 (ko) 2003-03-25 2005-07-11 이뮤노믹스 주식회사 인간 4-1비비 분자에 대한 인간화 모노클로날 폴리펩티드 및 이를 포함하는 약학 조성물
JP2007525458A (ja) * 2003-04-23 2007-09-06 メダレックス インコーポレイテッド インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体
JP2007535905A (ja) * 2003-06-06 2007-12-13 オンコマックス アクイジション コーポレイション 癌関連抗原ｓｍ５−１の特異抗体およびその用途
EP1648511A1 (en) * 2003-07-29 2006-04-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with enhanced effector function
US9403908B2 (en) 2003-09-29 2016-08-02 The Regents Of The University Of California Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
BRPI0922561A2 (pt) * 2008-12-09 2020-08-11 Pfizer Vaccines Llc vacina de peptídeo de ch3 da ige.

Similar Documents

Publication Publication Date Title
JP2013163673A5 (https=)
JP2017527272A5 (https=)
JP2008538919A5 (https=)
EP4249064A2 (en) Novel fusion protein specific for cd137 and pd-l1
JP2021514618A5 (https=)
JP2017518748A5 (https=)
HRP20120020T1 (hr) Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa
JP2010530220A5 (https=)
CN107847590A (zh) 针对白细胞介素36受体（il‑36r）的抗体
JP2006516195A5 (https=)
JP2004519475A5 (https=)
May et al. The P 1/P 2 proteins of the human ribosomal stalk are required for ribosome binding and depurination by ricin in human cells
JP2013535963A5 (https=)
CA2506580A1 (en) Assay kit and antibody for human low molecular weight cd14
PT1881064E (pt) Anticorpo monoclonal anti-núcleo de hcv
Milovnik et al. Selection and characterization of DARPins specific for the neurotensin receptor 1
JP2013511966A5 (https=)
US8183055B2 (en) Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
ES2561497T3 (es) Ligandos monovalentes del receptor CD28 humano
JP2008515388A5 (https=)
JP2017536821A5 (https=)
EP1560025A3 (en) Specific markers for diabetes
JP2020500150A (ja) 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
Stephenson et al. Identification of host insulin binding sites on Schistosoma japonicum insulin receptors
WO2007057778A3 (en) Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against tsh receptor